Only Korean pharmaceutical company to provide a complete Diabetes care Solution by offering high-quality affordable Insulin, Insulin Analogs to meet the unmet need of diabetes patients.
View moreAt UNDBIO our pipeline reflects to drive change to defeat Diabetes, Cancer, and Immunology related diseases. Our scientists are currently working on novel processes to make Insulin, Insulin Analogs, mAbs highly affordable
View more-
Partnering
UNDBIO is partnering with Drug-Device companies for Insulin Pump, Pen devices and Continuous Blood Glucose Monitoring System.
View more -
Injectable Portfolio
UNDBIO in Phase-2 will be stepping into Small Volume Parenteral, Large Volume Parenteral (Contrast media) and Extended-release Injectables.
View more